aspirin and glp-1 💊GLP-1s may protect against colorectal cancer faster than — therapeutic effects seen in 3 months vs 10 years for aspirin. Modulating insulin, inflammation & growth factor signaling could be the key GLP-1 drugs and colorectal cancer

A P value of 0.05 or less was considered statistically significant

It is highly context-dependent: organs such as the heart and brain, with high metabolic demand and limited regenerative capacity, are particularly vulnerable to resilience failure, whereas cancer cells exploit enhanced proteostasis resilience to support uncontrolled proliferation and therapy resistance

Jeffrey Egler, Nooms chief medical officer, noting more than 10,000 people have signed up

Research Context BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide corresponding to a 15-amino-acid partial sequence (residues 14 to 28) of a larger gastroprotective protein identified in human gastric juice